Thyroid hormone regulates adult hippocampal neurogenesis, a process involved in key functions, such as learning, memory, and mood regulation. We addressed the role of thyroid hormone receptor TR␣1 in adult hippocampal neurogenesis, using mice harboring a TR␣1 null allele (TR␣1 ؊/؊ ), overexpressing TR␣1 6-fold (TR␣2 ؊/؊ ), and a mutant TR␣1 (TR␣1 ؉/m ) with a 10-fold lower affinity to the ligand. While hippocampal progenitor proliferation was unaltered, TR␣1
Thyroid hormone perturbations in development cause major neuroanatomical and neurological deficits (1) . Though adult-onset hypothyroidism does not manifest as severely as developmental hypothyroidism (2) , it can precipitate depressive behavior and deteriorate cognitive function (3, 4) . In particular, adult hypothyroidism impairs hippocampus-dependent behaviors, resulting in learning, memory, and mood-related deficits (5, 6) . Adult hippocampal neurogenesis plays an important role in these hippocampus-dependent tasks (7, 8) , and is regulated by thyroid hormone (9 -11) . Decreased hippocampal neurogenesis has been postulated to contribute to the deficits in hippocampal functions observed in adult-onset hypothyroidism.
Adult neurogenesis encompasses progenitor proliferation, survival and differentiation, and the maturation and functional integration of newborn neurons (12) . The developmental stages of adult neurogenesis are characterized by stage-specific markers, such as nestin, NeuroD, doublecortin (DCX), polysialylated neural cell adhesion molecule (PSA-NCAM), stathmin, and calretinin (13, 14) . Adult hypothyroidism decreases progenitor survival, DCX-positive (DCX ϩ ) immature neuron number, and neuronal differentiation, with no effect on progenitor proliferation (9, 10) . In vitro evidence suggests a direct effect of thyroid hormone on adult hippocampal progenitors (10) . However, the role of thyroid hormone receptors (TRs) and their contribution to the damaging effects of hypothyroidism on adult hippocampal neurogenesis is unknown.
TRs are transcription factors that bind thyroid hormone response elements and activate or repress target genes as ligand-receptor complexes or aporeceptors (15) . TR ␣ and ␤ genes generate several TR isoforms, of which TR␣1, TR␣2, TR␤1, and TR␤2 are predominant in the adult mammalian brain (2) . TR␣1 contributes 70 -80% of total TR expression in the brain (16) . TR␣2 does not bind thyroid hormone, though some reports implicate TR␣2 in the transcriptional repression of thyroid hormone-responsive genes (17) . It is of interest to note that the phenotype in TR␣2 Ϫ/Ϫ mice, which as a consequence of ablation of TR␣2 inevitably overex-press TR␣1 severalfold, has been ascribed to TR␣1 aporeceptor effects in many tissues (18) .
It remains unclear whether the deleterious effects of hypothyroidism are due to insufficient target gene activation or a consequence of the aporeceptor acting as a transcriptional regulator (15) . The focus of the present study was to investigate the role of TR␣1 in adult hippocampal neurogenesis, using TR␣1 Ϫ/Ϫ , TR␣2 Ϫ/Ϫ , and TR␣1 ϩ/m heterozygous mice carrying a point mutation (TR␣1R384C) that lowers thyroid hormone affinity 10-fold (18 -20) . Further, TR␣1-GFP-expressing mice were used to address the stagespecific expression of TR␣1 in adult hippocampal progenitors. Our results demonstrate a key role for TR␣1 in the regulation of the postmitotic survival of adult hippocampal progenitors, and indicate that an unliganded TR␣1, acting as an aporeceptor, is responsible for the deleterious effects of hypothyroidism on adult hippocampal neurogenesis.
MATERIALS AND METHODS

Thyroid hormone receptor mutant mice
TR␣1
Ϫ/Ϫ and TR␣2 Ϫ/Ϫ mice were generated as described previously (18, 19) . The mouse strain carrying the dominantnegative R384C mutation in TR␣1 (TR␣1 ϩ/m ) was generated as described previously (20) . TR␣1-GFP-knock-in mice were constructed by inserting the coding sequence of eGFP in frame 3Ј to exon 9 of the TR␣1 gene (21) . Heterozygote offspring were bred against C57BL/6 for 3 generations and then intercrossed to generate TR␣1-GFP mice homozygous for the chimeric gene. TR␣1-GFP-knock-in mice have normal body and organ weights and T3, T4, and TSH levels, and show no overt morphological or physiological phenotype. The littermate mutant and wild-type mice were kept at 21°C on a 12:12-h light-dark cycle, and 2-mo-old male mice were used in the study. Animal care procedures were in accordance with the guidelines set by the European Community Council Directives (86/609/EEC) and were approved by the Karolinska Institutet and Tata Institute of Fundamental Research (TIFR) institutional animal ethics committees.
BrdU-labeling paradigms and drug treatments
To determine whether TR␣1 is expressed by proliferating adult hippocampal progenitors, we injected heterozygote TR␣1-GFP mice with a single intraperitoneal (i.p.) injection of the mitotic marker 5-bromo-2Ј-deoxyuridine [BrdU, 150 mg/kg body weight (bw); Sigma, St. Louis, MO, USA], 2 h prior to sacrifice (nϭ3). Male wild-type mice were used as a negative control to ensure specificity of the GFP signal. To address the effects on adult hippocampal progenitor proliferation, TR␣1
Ϫ/Ϫ and TR␣2 Ϫ/Ϫ mice, as well as littermate wild-type controls, received a single i.p. injection of BrdU (100 mg/kg bw; Sigma) and were sacrificed 2 h later (nϭ4 or 5/group). To address the role of an unliganded TR␣1 receptor on adult hippocampal progenitor proliferation, TR␣1
ϩ/m and wild-type littermate controls received a single BrdU (100 mg/kg bw) injection and were sacrificed 2 h later (nϭ4 -5/group).
To examine effects on the survival and differentiation of adult hippocampal progenitors, TR␣1
Ϫ/Ϫ and TR␣2
Ϫ/Ϫ mice, as well as littermate wild-type controls were administered BrdU (150 mg/kg bw) once daily by i.p. injection for 3 d and were sacrificed 28 d after the last injection (nϭ4 or 5/group). To examine the role of an unliganded TR␣1 receptor on adult hippocampal progenitor survival and differentiation, TR␣1 ϩ/m and wild-type littermate controls received a single daily BrdU (100 mg/kg bw) injection for 3 d and were sacrificed 30 d later (nϭ4 or 5/group).
Experiments to address the influence of thyroid hormone treatment on adult hippocampal progenitor survival in TR␣2 Ϫ/Ϫ mice had 4 experimental groups: wild type ϩ vehicle, wild type ϩ T3, TR␣2
Ϫ/Ϫ ϩ vehicle, and TR␣2 Ϫ/Ϫ ϩ T3 (nϭ4 or 5/group). The groups receiving thyroid hormone treatment were given T3 (0.5 g/ml, Sigma) in drinking water, as described previously (22) 
In experiments to examine the effect of thyroid hormone treatment on adult hippocampal progenitor survival and differentiation in TR␣1 ϩ/m mice, there were 4 experimental groups: wild type ϩ vehicle, wild type ϩ T3, TR␣1
ϩ/m ϩ vehicle, and TR␣1 ϩ/m ϩ T3 (nϭ4 -5/group). The treatment groups (wild type ϩ T3, TR␣1
ϩ/m ϩ T3) received T3 (0.5 g/ml) in drinking water, as described previously (22) 
Immunohistochemistry
Mice were sacrificed by transcardial perfusion with 4% PFA, brains were removed, postfixed, and subsequently cryoprotected in 30% sucrose-PFA. Serial coronal sections (30 m) through the rostrocaudal extent of the hippocampus were generated using a freezing microtome (Leica, Wetzlar, Germany). Free-floating sections were processed for BrdU immunohistochemistry as described previously (10) . In brief, after DNA denaturation and acid hydrolysis, sections were incubated overnight with mouse anti-BrdU antibody (1:500; Boehringer Mannheim, Indianapolis, IN, USA). Sections were then exposed to secondary antibody (biotinylated antimouse IgG, 1:500, Vector Laboratories, Burlingame, CA, USA). An avidin-biotin complex (Vector Laboratories) was used for signal amplification, which was detected using the substrate diaminobenzidine (Sigma).
For immunohistochemistry and immunofluorescence experiments to examine the expression of endogenous markers of either immature neurons (DCX, PSA-NCAM) or the neurogenic niche (NeuroD, stathmin) in the adult hippocampus, tissue sections were blocked using 10% horse serum in phosphate buffer prior to overnight exposure at room temperature to the following antibodies: goat anti-DCX (1:250, Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse anti-PSA-NCAM (1:500; kind gift from Prof. T. Seki, Juntendo University, Tokyo, Japan; ref. 23) , rabbit anti-stathmin (1:250; Calbiochem, San Diego, CA, USA), and goat anti-NeuroD (1:200; Santa Cruz Biotechnology). Following washes in 0.1 M phosphate buffer, sections were incubated with secondary antibodies: biotinylated anti-goat IgG (1:250; Vector Laboratories), Alexa 488-conjugated donkey anti-mouse (1:250; Molecular Probes, Eugene, OR, USA), Alexa 488-conjugated donkey anti-rabbit (1:250, Jackson ImmunoResearch, Bar Harbor, ME, USA) at room temperature for 3 h. An avidinbiotin complex (Vector Laboratories) was used for signal amplification of biotinylated secondary antibodies, which was then detected with diaminobenzidine (Sigma). To visualize immunofluorescence, sections were mounted in Vectashield (Vector Laboratories) and viewed using a Nikon Eclipse 90i fluorescence microscope (Nikon, Tokyo, Japan).
For experiments to address the neuronal differentiation of adult dentate granule cell progenitors, double-labeling experiments were carried out. Sections were incubated overnight with the following primary antibody cocktails: rat anti-BrdU (1:500; Accurate Biochemicals, Westbury, NY, USA) with mouse anti-neuronal nuclei (NeuN) (1:1000; Chemicon, Temecula, CA, USA) to assess the neuronal differentiation of adult hippocampal progenitors; or rat anti-BrdU (1:500; Covance, Vienna, VA, USA) with rabbit anti-calretinin (1:250; Swant, Bellinzona, Switzerland) to examine the colocalization of BrdU with the transient immature neuron marker, calretinin. Sections were then incubated with the following cocktails of secondary antibodies: biotinylated anti-rat IgG (1:500; Chemicon) with Alexa 555-conjugated anti-mouse (1:250; Molecular Probes) or Cy3-conjugated donkey anti-rat and FITC-conjugated donkey anti-mouse (both 1:250; Jackson ImmunoResearch). Signal amplification was performed using FITC-conjugated streptavidin (1:250; Molecular Probes), following which sections were mounted using Vectashield (Vector Laboratories). Sections were observed with a Zeiss Axiovert confocal laser scanning microscope (510LSM; Carl Zeiss, Oberkochen, Germany) to determine immunofluorescence colocalization using confocal z-plane sectioning.
For experiments to determine the neuronal or glial differentiation of adult dentate granule cell progenitors, triplelabeling studies were carried out. Sections were incubated overnight with a cocktail of primary antibodies: rat anti-BrdU (1:500; Accurate Biochemicals) with mouse anti-NeuN (1: 1000; Chemicon) and rabbit anti-glial fibrillary acidic protein (GFAP; 1:500; Chemicon). Sections were incubated with a cocktail of secondary antibodies: biotinylated anti-rat IgG (1:500; Chemicon) with Alexa 555-conjugated anti-mouse (1:250; Molecular Probes) and Cy5-conjugated anti-rabbit (1:500; Chemicon), followed by incubation with Alexa 488-conjugated streptavidin (1:500, Molecular Probes). Sections were mounted using Vectashield (Vector Laboratories), and immunofluorescence colocalization was determined using confocal z-plane sectioning with an Olympus Fluoview FV 1000 laser scanning microscope (Olympus, Tokyo, Japan).
For double labeling in TR␣1-GFP mice, sections were incubated overnight with rabbit anti-GFP (1:5000; Abcam, Cambridge, UK) along with either goat anti-NeuroD (1:200) or goat anti-DCX (1:250; both Santa Cruz Biotechnology), followed by a cocktail of secondary antibodies: anti-goat Alexa 594 and anti-rabbit Alexa 488 (both 1:1000; Invitrogen, Stockholm, Sweden). For BrdU double-labeling, the sections were first incubated with anti-GFP primary and secondary antibodies before BrdU pretreatment and immunohistochemistry, as described above. The GFP signal was specific as demonstrated by the lack of any immunofluorescence with an anti-GFP antibody in wild-type mice. Colocalization of GFP signal in TR␣1-GFP mice with the markers (BrdU, NeuroD, and DCX) was examined using confocal z-stack images on a Zeiss Axiovert confocal laser-scanning microscope (510LSM). For all immunohistochemistry and immunofluorescence experiments, the specificity of antibody signal was confirmed using the following controls: absence of primary antibody, or isotype-matched IgG controls.
Cell counting
Quantitation of BrdU ϩ cell numbers in hippocampal sections was carried out using a previously described modified, unbiased stereology protocol (24) on a Zeiss Axioskop microscope. Sections spanned the rostrocaudal extent of the hippocampus (bregma Ϫ1.34 to Ϫ3.80) (25) , and every 6th hippocampal section was processed for quantitation (12 sections/animal). Sections were coded, and the quantitation was conducted by an experimenter masked to the code. BrdU ϩ cells within dentate gyrus (DG) were counted as being in the subgranular zone (SGZ)/granule cell layer (GCL) when they were directly touching the SGZ or within it. The total number of BrdU ϩ cells in the SGZ/GCL was estimated by multiplying the total number of BrdU cells counted from every 6th section by the section periodicity, 6.
Quantitation of DCX ϩ cells in hippocampal sections was carried out by an experimenter masked to the study code. (26) . Quantitation of both DCX ϩ cell numbers and morphological category was performed under masked conditions using a Zeiss Axioskop at ϫ400.
Quantitation of proliferating cell nuclear antigen (PCNA), PSA-NCAM, stathmin, and NeuroD ϩ cells was performed using the same approach used for quantitation of DCX ϩ cell numbers.
To examine the differentiation of BrdU ϩ progenitors into neurons or glia in the TR␣1 Ϫ/Ϫ and TR␣2 Ϫ/Ϫ mice, the percentage of BrdU ϩ cells that colocalized with the neuronal marker NeuN or the glial marker GFAP was determined using confocal microscopy. In each animal (nϭ5/group), 20 BrdU ϩ cells were analyzed using z-plane sectioning with 0.41-m steps on an Olympus Fluoview FV100 laser-scanning confocal microscope to confirm colocalization with either NeuN or GFAP. In the TR␣1 ϩ/m mice, 50 BrdU ϩ cells in each animal per marker were analyzed to confirm colocalization with either the transient neuronal marker calretinin or the mature neuronal marker NeuN, using z-plane sectioning on a Zeiss Axiovert 510LSM confocal laser-scanning microscope. Percentage colocalization of BrdU with either NeuN or calretinin was determined for BrdU ϩ cells within the SGZ/ GCL or directly in contact with the SGZ and was confirmed using z-plane stack analysis of confocal images.
In TR␣1-GFP mice, 20 BrdU, NeuroD, or DCX-immunopositive cells per animal (nϭ3) were analyzed for colocalization with GFP using z-plane sectioning on a Zeiss Axiovert 510LSM confocal laser-scanning microscope.
Statistical analysis
Results were subjected to statistical analysis using the program Prism (GraphPad, San Diego, CA, USA). Experiments with two groups were analyzed for differences using the unpaired Student's t test, with significance determined at P Ͻ 0.05. Experiments with 4 groups were subjected to statistical analyses using analysis of variance (ANOVA) followed by the Bonferroni post hoc test, with significance determined at values of P Ͻ 0.05.
RESULTS
TR␣1 is expressed in newborn neurons of the adult hippocampus
Given recent evidence that thyroid hormone regulates adult hippocampal neurogenesis (9 -11) and that the most abundant thyroid hormone receptor isoform in the brain is TR␣1 (16), we sought to further elucidate the function of this receptor in hippocampal neurogenesis. To examine the expression of the TR␣1 receptor in adult hippocampal progenitors, we used a novel knock-in TR␣1-GFP mouse strain generated by inserting the coding sequence of eGFP in frame with the TR␣1 gene. In the hippocampus, GFP expression was observed within nuclei of cells in the SGZ and the GCL of the DG subfield. Double immunohistochemistry for the mitotic marker BrdU and GFP was performed to determine whether TR␣1 is expressed by the proliferating pool of adult hippocampal progenitors. The lack of colocalization of TR␣1-GFP with BrdU in hippocampal progenitors (Fig. 1A) indicated that this receptor was not expressed by proliferating progenitor cells within the SGZ in the DG. To address whether TR␣1 is expressed later in neuronal development, i.e., in the largely postmitotic pool of adult hippocampal progenitors, we performed double immunohistochemistry for GFP and 2 markers for immature neurons; NeuroD and DCX. Confocal analysis revealed that TR␣1 was expressed in both NeuroD and DCX ϩ progenitors in the SGZ and GCL within the DG (Fig. 1B, C) . These results indicate that within the neurogenic niche of the adult hippocampus, TR␣1 is predominantly expressed by postmitotic progenitors destined to acquire a neuronal fate, and does not appear to be present in proliferating progenitors. On the basis of these findings along with our previous results (10), we hypothesized that TR␣1 plays a role in the survival of adult hippocampal progenitors, and used mice lacking or harboring a mutation in the TR␣ isoforms to further investigate this hypothesis.
Proliferation of adult hippocampal progenitors is unaffected in the DG of TR␣1
؊/؊ and TR␣2
Male TR␣1
Ϫ/Ϫ mice and wild-type littermate controls were injected with BrdU 2 h prior to sacrifice in order to assess the influence of TR␣1 receptor loss on the proliferation of adult hippocampal progenitors (Fig. 2) . Stereological analysis indicated no change in the number of BrdU ϩ progenitors in the SGZ/GCL of TR␣1
mice as compared to wild-type animals ( Fig. 2A , left graph). We also examined the expression of an endogenous marker of cell division, PCNA, and the number of PCNA ϩ cells in the SGZ/GCL was unaltered in TR␣1 Ϫ/Ϫ mice ( Fig. 2A, right graph) . We next examined the numbers of BrdU-and PCNA ϩ cells in the SGZ/GCL of TR␣2 Ϫ/Ϫ mice that overexpress TR␣1 as a direct consequence of the gene-targeting strategy. TR␣2 Ϫ/Ϫ mice do not exhibit any change in the number of BrdU-or PCNA ϩ cells within the SGZ/GCL, indicating no effect in these mice on hippocampal progenitor proliferation (Fig. 2B, graphs) . In both wild-type and TR␣1-and TR␣2-deficient mice, BrdUand PCNA ϩ cells were observed in clusters within the SGZ at the border of the GCL and the hilus. Ϫ/Ϫ mice showed a significant increase in the number of BrdU ϩ cells in the SGZ/GCL as compared to wild-type controls, which indicated an increased survival of adult hippocampal progenitors in the mutants (Fig. 3A, right panel) . In striking contrast, TR␣2 Ϫ/Ϫ mice demonstrated a significant decline in the number of persisting BrdU ϩ cells in the SGZ/GCL (Fig. 3B, right panel) . The surviving BrdU ϩ cells exhibit a characteristic ovoid shape and are not observed in clusters but are seen dispersed through the GCL (Fig. 3 , image panels).
TR␣1
؊/؊ and TR␣2 ؊/؊ mice exhibit contrasting effects on the numbers of DCX ؉ immature neurons in the adult DG DCX is a microtubule-associated protein expressed by postmitotic and migratory adult hippocampal progenitors (12) and is a useful endogenous marker for adult hippocampal neurogenesis) . TR␣1 Ϫ/Ϫ mice exhibited Figure 1 . TR␣1 is expressed in Neuro-D-and DCX ϩ progenitors within the DG. TR␣1-GFP-knock-in mice generated by insertion of the coding sequence of eGFP in frame with the TR␣1 gene were utilized to study the expression of TR␣1-GFP chimeric protein using double immunofluorescence studies. TR␣1-GFP-knock-in mice received a single injection of BrdU (150 mg/kg, nϭ3) and were sacrificed 2 h later. A) Confocal z-stack image at ϫ630, indicating the lack of colocalization of TR␣1-GFP with BrdU within the SGZ of the DG. B) NeuroD ϩ progenitors within the SGZ and GCL of the DG colocalized with GFP, as shown in a representative confocal z-stack image (ϫ630). C) DCX-immunopositive immature neurons were also observed to exhibit colocalization with GFP at ϫ630, indicating the presence of TR␣1 in DCX ϩ immature neurons. a significant increase in the number of DCX ϩ cells/ section within the SGZ/GCL (Fig. 4A, right panel) , whereas TR␣2 Ϫ/Ϫ mice had reduced DCX ϩ cell numbers as compared to their wild-type controls (Fig. 4 B,  right panel) . Taken together, the BrdU and DCX results indicate an increased hippocampal neurogenesis in TR␣1
Ϫ/Ϫ mice in contrast to the decrease seen in the TR␣2 Ϫ/Ϫ strain. DCX immunohistochemistry marks both the cell body and the dendritic arbors of newborn neurons (Fig. 4A, B) . As immature neurons undergo a morphological maturation, the dendritic tree becomes more elaborate with the presence of complex tertiary dendrites. As described previously (26), we subcategorized DCX ϩ cells as those with or without tertiary dendrites (Fig. 4C, left 
؊/؊ and TR␣2 ؊/؊ mice show an altered expression of markers of the neurogenic niche
Immunohistochemical analyses were performed to determine whether TR␣1
Ϫ/Ϫ and TR␣2 Ϫ/Ϫ mice exhibit changes in expression of additional stage-specific markers for adult hippocampal neurogenesis, such as PSA-NCAM and stathmin, which have previously been shown to colocalize with DCX expression (13, 27, 28) . Fig. 5D ) as compared to their wild-type controls. While PSA-NCAM expression (Fig. 5A, B) was noted in both the cell body, as well as the dendritic arbor similar to DCX expression, stathmin expression (Fig. 5C, D) was predominantly observed in the cell body. Taken together, our results demonstrate that TR␣1 Ϫ/Ϫ mice show a significant increase, while TR␣2 Ϫ/Ϫ mice exhibit a decline, in the number of DCX-, PSA-NCAMand stathmin-positive cells within the adult hippocampal neurogenic niche.
We also sought to address whether the TR␣1 Ϫ/Ϫ and TR␣2 Ϫ/Ϫ mice exhibit any gross changes in hippocampal and GCL volume using modified stereological approaches (10). We observed no significant change in either the total hippocampal volume or in the volume of the GCL in the DG hippocampal subfield in the TR␣1 Ϫ/Ϫ or TR␣2 Ϫ/Ϫ mice, as compared to their respective littermate wild-type controls (Supplemental . 1) . Further, granule cell neuron marker (Prox1) expression, mossy fiber bundle innervation of the CA3, and GFAP-immunopositive glial cell numbers in the DG subfield were found to be unaltered in the TR␣1 Ϫ/Ϫ or TR␣2 Ϫ/Ϫ mice as compared to their respective littermate wild-type controls (Supplemental Figs. 2 and 3) .
Differentiation of newborn progenitors is not perturbed in TR␣1
؊ 
Thyroid hormone administration to TR␣2
؊/؊ mice rescues the decline in the number of DCX
؉ immature neurons
We hypothesized that the decreased survival of BrdU ϩ progenitors and the decline in DCX, PSA-NCAM, and stathmin cell numbers in TR␣2 Ϫ/Ϫ mice may reflect a limited availability to ligand for the overexpressed TR␣1, thus causing an aporeceptor effect in the neurogenic niche similar to those described previously for other tissues (18) . To test this hypothesis, we treated the TR␣2 Ϫ/Ϫ mice with excess thyroid hormone. Animals were divided into 4 groups, with TR␣2 Ϫ/Ϫ mice and their wild-type controls receiving either vehicle or thyroid hormone in drinking water for 16 d prior to sacrifice. We then assessed whether the hormone treatment could rescue the decrease in number of hippocampal progenitors expressing the endogenous marker, DCX, in the TR␣2 Ϫ/Ϫ mice. Thyroid hormone treatment was capable of completely rescuing the decline in DCX ϩ cell number in the SGZ/GCL of TR␣2 Ϫ/Ϫ mice (Fig. 7B) . Interestingly, thyroid hormone treatment also significantly enhanced the number of DCX ϩ cells in the SGZ/GCL of wild-type animals. These results support the hypothesis that the decrease in progenitor survival observed in TR␣2 Ϫ/Ϫ mice, is a consequence of a TR␣1 aporeceptor effect, which can be ameliorated through the restoration of an appropriate ligand-receptor ratio via thyroid hormone treatment.
Rescue of survival and neuronal differentiation of adult hippocampal progenitors in TR␣1
؉/m mice by thyroid hormone administration
To further address the hypothesis that an unliganded TR␣1 results in a decline in adult hippocampal neurogenesis, we used mice expressing a mutant TR␣1 with dominant-negative activity. These heterozygous mice (TR␣1 ϩ/m ) were generated by introducing a point mutation in the TR␣1 gene (TR␣1R384C) that lowers the affinity for thyroid hormone 10-fold (20) . We first studied the effects of reduced ligand-binding in TR␣1 ϩ/m mice on adult hippocampal progenitor proliferation. Wild-type controls and TR␣1 ϩ/m mice received a single BrdU injection and were sacrificed 2 h later. BrdU immunohistochemistry followed by stereological quantitative analysis showed that mutant mice did not differ from wild-type animals in the number of BrdU ϩ cells; these results were corroborated by PCNA immunohistochemistry (Fig. 8A, B) . To examine the survival of BrdU ϩ progenitors in the hippocampus, wild-type controls and TR␣1 ϩ/m mice were injected with BrdU once daily for 3 d and sacrificed 30 d after the last BrdU injection. As compared to wild-type mice, a significant decrease in the number of surviving BrdU ϩ cells was seen in TR␣1 ϩ/m mice. Thyroid hormone treatment of TR␣1 ϩ/m mice normalized the numbers of surviving BrdU ϩ cells as compared to vehicle-treated wild-type controls (Fig. 8D) . Interestingly, thyroid hormone treatment to wild-type controls itself resulted in an increased number of BrdU ϩ cells that persisted 30 d after BrdU injection. Taken together, with the results obtained from the TR␣2 Ϫ/Ϫ mice, the data indicate that an unliganded TR␣1 receptor could function as an inhibitor of adult hippocampal neurogenesis through an effect on the survival of newborn hippocampal progenitors.
To determine whether the unliganded TR␣1 influences the differentiation of BrdU ϩ progenitors into mature neurons, double-labeling studies were performed using antibodies to BrdU and NeuN. Confocal analysis revealed a significant reduction in the percentage of BrdU ϩ cells that are immunopositive for the neuronal marker NeuN (Fig. 8E) indicating that fewer progenitor cells acquire a neuronal phenotype in TR␣1 ϩ/m mice. Thyroid hormone treatment ameliorated the decrease in neuronal differentiation observed in TR␣1 ϩ/m mutant mice (Fig. 8E) . However, thyroid hormone treatment to wild-type mice did not influence neuronal differentiation. These results suggest that unliganded TR␣1 influences both hippocampal progenitor cell survival and neuronal differentiation.
Given the decline observed in BrdU/NeuN colocalization in TR␣1
ϩ/m mice, we next sought to address whether the expression of calretinin in BrdU ϩ postmitotic hippocampal progenitors is also altered in TR␣1 ϩ/m mice. Calretinin, a calcium-binding protein, is transiently expressed in the postmitotic stages of hippocampal progenitor cell development (29) , and calretinin-immunopositive cells represent a fraction of immature, postmitotic adult hippocampal progenitors that are destined for neuronal differentiation. Calretinin expression is thought to precede the expression of the mature neuronal marker NeuN. Confocal analysis revealed a significant decline in the colocalization of BrdU with calretinin in the TR␣1 ϩ/m mice, which was partially normalized by thyroid hormone treatment (Fig. 8F) .
Decrease in NeuroD
؉ cells in the hippocampal neurogenic niche of TR␣2 ؊/؊ and TR␣1 ؉/m mice
The transcription factor NeuroD is required for the differentiation of dentate granule cells of the hippocampus (30) and is expressed in adult hippocampal progenitors (31, 32) . We examined by immunohistochemistry the number of NeuroD ϩ cells within the SGZ/GCL of TR␣2 Ϫ/Ϫ and TR␣1 ϩ/m mice. In wild-type mice, NeuroD was strongly expressed in the SGZ where adult hippocampal progenitors reside, whereas the expression was substantially lower in the GCL (Fig. 9A, C) . In both mutant mouse strains we observed a significant reduction in the number of NeuroD-immunopositive cells within the SGZ/ GCL as compared to their respective wild-type controls (Fig. 9) . Thyroid hormone treatment normalized the number of NeuroD ϩ cells in TR␣1 ϩ/m mice (Fig. 9D ). In the TR␣2 Ϫ/Ϫ mice, thyroid hormone treatment showed a trend to increase the number of NeuroD ϩ cells/section; however, this did not reach significance (Pϭ0.06, ANOVA and Bonferroni post hoc test; Fig. 9B ). Interestingly, thyroid hormone treatment resulted in a significant increase in NeuroD ϩ cell number in wild-type control littermates from both the TR␣2 Ϫ/Ϫ and TR␣1 ϩ/m experiments (Fig.  9B, D) .
DISCUSSION
Our aim in this study was to address the role of TR␣1 in adult hippocampal neurogenesis using TR␣1 Ϫ/Ϫ , TR␣2 Ϫ/Ϫ , and TR␣1 ϩ/m mutant mice. We provide novel evidence that TR␣1 regulates adult hippocampal neurogenesis, through effects on progenitor survival and neuronal differentiation. The striking similarity between the decreased adult neurogenesis observed in hypothyroidism (9, 10), and our results of the neurogenic phenotype in mutant mice with TR␣1 aporeceptor activity, strongly suggest that an unliganded TR␣1 contributes to the neurogenic decline in adult-onset hypothyroidism.
While the requirement for thyroid hormone during neurodevelopment is well established (33, 34) , it is only recently that the effects of thyroid hormone on adult neurogenesis have been reported (9, 10, 11, 35) . Impaired adult hippocampal neurogenesis is implicated as a key structural correlate that contributes to the functional deficits in hippocampus-dependent learning and mood-related behaviors observed in rodents and hu- ϩ/m and wild-type littermate controls received a single BrdU (100 mg/kg) injection and were sacrificed 2 h later. Adult hippocampal progenitor proliferation was also assessed using immunohistochemistry for the endogenous mitotic marker PCNA. A) Representative images of PCNA immunofluorescence at ϫ200 from a TR␣1 ϩ/m mouse and a wild-type control. PCNA ϩ progenitors were observed in clusters within the SGZ/GCL. B) There was no significant difference in the number of cells expressing PCNA or in the number of proliferating BrdU ϩ cells in the SGZ/GCL of TR␣1 ϩ/m mice vs. wild-type controls. C, D) To examine adult hippocampal progenitor survival and differentiation, TR␣1 ϩ/m mice and wild-type controls received daily administration of BrdU (150 mg/kg) for 3 d and were sacrificed 30 d after the final BrdU administration, as described in Materials and Methods. To address whether thyroid hormone treatment could rescue the effects on progenitor survival and differentiation observed in TR␣1 ϩ/m mice, animals were divided into 4 experimental groups (wild type ϩ veh, TR␣1 ϩ/m ϩ veh, wild type ϩ T3, and TR␣1 ϩ/m ϩ T3). Thyroid hormone treatment was administered in drinking water as described in Materials and Methods. C) Representative photomicrographs of BrdU immunohistochemistry at ϫ200 in the SGZ/GCL of vehicle and T3-treated wild-type and TR␣1 mans with adult-onset hypothyroidism (4, 11, 36) . However, the role of individual TRs in adult neurogenesis remains largely unidentified, with a single report (35) suggesting a role for TR␣ isoforms in the regulation of progenitor cell cycling in the subventricular zone lining the lateral ventricles.
Approximately 75% of thyroid hormone binding by TRs in the adult rodent brain is accounted for by TR␣1 (16, 37) . Immunohistochemical evidence indicates TR␣ isoform expression in adult hippocampal progenitors (10), but their stage-specific expression is unknown. Our colocalization studies of the TR␣1-GFP chimeric protein with stage-specific progenitor markers indicate TR␣1 expression in NeuroD and DCX-immunopositive progenitors, but not in proliferating BrdU ϩ progenitors. Our unpublished results with the TR␣1-GFP-knock-in mice indicate that TR␣1 expression is restricted to postmitotic stages of neuronal progenitor development. Further, proliferation was not altered in TR␣1 Ϫ/Ϫ mice, TR␣2 Ϫ/Ϫ mice, or TR␣1 ϩ/m mutant mice. Taken together, these results imply that neither TR␣1 nor TR␣2 influence adult hippocampal progenitor proliferation. This is interesting in light of previous evidence (9, 10) that indicate no change in progenitor turnover following hypothyroidism or hyperthyroidism, suggesting a role for thyroid hormone in the postmitotic stages of adult hippocampal progenitor development. TR␣1 Ϫ/Ϫ mice exhibited an increased survival of adult hippocampal progenitors, in striking contrast to the TR␣1-overexpressing TR␣2
Ϫ/Ϫ mice that show a significant decline in progenitor survival. It could be argued that the decrease in postmitotic progenitor survival in the TR␣2 Ϫ/Ϫ mice is a consequence of TR␣1 overexpression, or TR␣2 loss, or a combination of both. However, we hypothesized, on the basis of the previously described phenotype of the TR␣2 Ϫ/Ϫ mice (18) that the overexpression of TR␣1 may result in aporeceptor activity due to limited availability to ligand, and therefore reduced postmitotic survival of adult hippocampal progenitors. Strong support for this hypothesis comes from our results with the TR␣1 ϩ/m mice that express a mutant TR␣1 with aporeceptor activity, which show a robust decline in adult hippocampal progenitor survival. Both the TR␣2 Ϫ/Ϫ and TR␣1 ϩ/m mice show a phenotype similar to hypothyroidism with decreased hippocampal progenitor survival, adding credence to the hypothesis that a TR␣1 aporeceptor contributes to the deleterious consequences of hypothyroidism on adult hippocampal neurogenesis (Fig. 10) . Interestingly, TR␣1 deficiency enhances hippocampal progenitor survival suggesting the possibility that in the TR␣1 Ϫ/Ϫ mice, besides the loss of liganded TR␣1, the removal of a strong repressor activity of unliganded TR␣1 may underlie the increased progenitor survival.
The cellular mechanisms for the effects of TR␣1 on hippocampal progenitor survival are at present unclear. However, it is tempting to draw parallels with the proposed mechanisms for the actions of TR␣1 on embryonic neuronal progenitors. Unliganded TR␣1 has been suggested to arrest neuronal progenitors at specific stages of development until ligand availability allows them to progress further into neuronal differentiation (38) . Adult hippocampal progenitors may recapitulate the effects of TR␣1 aporeceptors observed in their developmental counterparts, with the TR␣1 aporeceptor affecting expression of genes relevant for the progression of adult hippocampal progenitors to the next developmental stage. Indeed in both the TR␣2 Ϫ/Ϫ and TR␣1 ϩ/m mice, the decline in progenitor survival suggests that TR␣1 aporeceptors may result in postmitotic progenitors being arrested during maturation, with an eventual cell loss in the absence of a rescue by the ligand. Further support for this idea comes from our observations that thyroid hormone administration to TR␣2
Ϫ/Ϫ and TR␣1 ϩ/m mice rescues the decreased survival observed using either an endogenous marker (DCX) or exogenous label (BrdU). The data also indicate that thyroid hormone treatment to wild-type mice increases hippocampal progenitor survival. Our results lead us to speculate that the effects of thyroid hormone on adult hippocampal neurogenesis may largely involve an alleviation of the TR␣1 aporeceptor effect. A question that remains at present is whether the actions of TR␣1, either liganded or unliganded, on adult hippocampal progenitor survival involve cell autonomous or noncell autonomous effects via modulation of the neurogenic niche. We have previously shown that thyroid hormone does exert direct effects on hippocampal progenitors in vitro (10) ; however, the in vitro effects differ substantially from the effects of perturbed thyroid hormone levels in vivo, indicating that dispersed progenitor cultures do not recapitulate the in vivo neurogenic niche vis a vis responses to thyroid hormone. Future studies that address the influence of TR␣1 on neurogenic niche trophic factor expression, deiodinase expression in the hippocampal neurogenic niche and on astrocytic release of regulatory factors would further our mechanistic understanding of the effects of TR␣1 on hippocampal neurogenesis.
Besides its effects on hippocampal progenitor survival, adult-onset hypothyroidism also significantly decreases neuronal differentiation, an effect relieved by thyroid hormone treatment (9, 10) . The TR␣1 ϩ/m mice exhibit a significant decline in the survival and neuronal differentiation of hippocampal progenitors, both of which can be rescued by thyroid hormone. This strong phenotypic similarity suggests that unliganded TR␣1 may account for all of the changes observed in hippocampal neurogenesis in hypothyroidism. However, it is important to note that TR␣2 Ϫ/Ϫ mice, that overexpress TR␣1, despite a robust decline in progenitor survival show normal neuronal differentiation of hippocampal progenitors, indicating a difference from the TR␣1 ϩ/m mice. This discrepancy is likely to be due to the weak aporeceptor activity of TR␣1 in the TR␣2 Ϫ/Ϫ mice, as caused by the receptor overexpression, as compared to the relatively much stronger aporeceptor activity caused by the point mutation in the TR␣1R384C mutant receptor. Other contributing factors may include the differences in TR stoichiometry in these mutant mice. Future studies addressing the regulation of key target genes that modulate hippocampal progenitor survival and neuronal differentiation may help to resolve these issues. The TR␣1 Ϫ/Ϫ mice Figure 10 . A) Schematic of the developmental stage-specific expression of markers by adult hippocampal progenitors. ) mutant mice with a 10-fold reduction in affinity for thyroid hormone all show a decline in adult hippocampal neurogenesis, through a decrease in the survival of postmitotic neuroblasts. These effects are thought to arise as a consequence of repressor effects on the postmitotic survival of adult hippocampal progenitors induced by a TR␣1 aporeceptor. A change in the ratio of unliganded and liganded TR␣1 receptors may contribute via TR␣1 aporeceptor effects to the impaired adult hippocampal neurogenesis observed in adult-onset hypothyroidism.
that show enhanced hippocampal progenitor survival exhibit normal neuronal differentiation, suggesting that deficiency of this receptor may not be capable of further enhancing the neuronal differentiation of adult hippocampal progenitors.
We further addressed the early stages of postmitotic hippocampal progenitor development using two different markers, calretinin and NeuroD. Calretinin is a transient marker of postmitotic hippocampal progenitors destined for neuronal differentiation (29) . The TR␣1 ϩ/m mice show decreased BrdU-calretinin percentage colocalization, which can be rescued by thyroid hormone. Thyroid hormone administration to wildtype mice enhances the percentage of BrdU-labeled progenitors that are calretinin-immunopositive. Since we observed an influence of TR␣1 aporeceptors on the calretinin-positive stage of neuronal differentiation in adult hippocampal progenitors, we examined whether an earlier stage of fate choice, namely, the acquisition of neuronal fate through the transcription factor NeuroD is also influenced. We observed a robust decline in NeuroD ϩ cell numbers within the hippocampal neurogenic niche of both TR␣1
ϩ/m and TR␣2 Ϫ/Ϫ mice, which could be rescued by thyroid hormone administration. NeuroD is expressed in adult hippocampal progenitor cells (31) and is essential for progenitor survival and neuronal differentiation (30, 39) . Furthermore, NeuroD expression is regulated by thyroid hormone, and hypothyroidism reduces NeuroD expression in the developing rat cerebellum (40) and the adult hippocampus (unpublished results). There are strong parallels to the effects of thyroid hormone on myogenic differentiation, where the TR␣1 aporeceptor represses the transcription of the myogenic transcription factor, MyoD (41) . Our results suggest that TR␣1 aporeceptor activity may hold hippocampal progenitors at the early postmitotic stage prior to the acquisition of NeuroD ϩ identity and the commitment to a neuronal fate. The ligand thyroid hormone could act to allow progression of neuronal differentiation, and on the basis of reports that thyroid hormone cooperates with neurotrophins during hippocampal development (42) may also modulate the sensitivity of these postmitotic progenitors to neurotrophins within the niche.
Previous reports demonstrate that TR␣1 ϩ/m mice also exhibit depressive behavior (43) , anxiety, and memory impairments that are rescued by thyroid hormone treatment (22) . Given the role of adult hippocampal neurogenesis in hippocampal-dependent memory (7, 44) , depression (8) , and anxiety behavior (45) , this highlights the possibility that decreased hippocampal neurogenesis as a consequence of TR␣1 aporeceptor activity may contribute to the behavioral deficits observed in both hypothyroidism and TR␣1 ϩ/m mutant mice. In contrast, the TR␣1 Ϫ/Ϫ mice exhibit enhanced fear-associated learning, a behavior known to require hippocampal neurogenesis (46) . The increased neurogenesis that we observed in the TR␣1 Ϫ/Ϫ mice may contribute to the improved fear of learning. However, the TR␣1 Ϫ/Ϫ mice also exhibit enhanced anxiety behavior, which has a more controversial association with neurogenesis, with increased anxiety behavior observed both following a decline or induction in hippocampal neurogenesis (47, 48) . Our results motivate studies to determine the contribution of the neurogenic changes observed in the TR␣1 mutants to the behavioral phenotypes observed in these mice. In summary, we provide definitive evidence that TR␣1 regulates adult hippocampal neurogenesis. Further, our data strongly indicate that TR␣1 aporeceptor activity mediates the impaired survival and neuronal differentiation of adult hippocampal progenitors in adult-onset hypothyroidism. Our results highlight the requirement for future studies to identify the target genes that are regulated by both TR␣1 apo-and holo-receptor activity, and their contribution to the decreased hippocampal neurogenesis and cognitive/behavioral deficits observed in adult-onset hypothyroidism. 
